In the wake of the increase in Current Liabilities in the second quarter 2026, Quick Ratio fell to 0.26 below Harvard Bioscience Inc average.

Within Laboratory Analytical Instruments industry 17 other companies have achieved higher Quick Ratio than Harvard Bioscience Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 2431 to 3172.

Explain Quick Ratio?
How much Cash & cash equivalents HBIO�s has?
What are HBIO�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

HBIO Quick Ratio	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3	(Jun 30 2025) Q2
Y / Y Current Liabilities Change	-52.38 %	-61.29 %	-63.81 %	170.26 %	179.72 %
Y / Y Cash & cash equivalent Change	-12.62 %	27.98 %	109.69 %	49.2 %	83.84 %
Quick Ratio MRQ	0.26	0.35	0.47	0.13	0.14
HBIO's Total Ranking	# 3172	# 2431	# 1923	# 2478	# 2887
Seq. Current Liabilities Change	22.76 %	9.1 %	-64.06 %	-1.04 %	-0.22 %
Seq. Cash & cash equivalent Change	-8.38 %	-17.6 %	26.36 %	-8.4 %	34.19 %

Quick Ratio second quarter 2026 Company Ranking
Within:	No.
Laboratory Analytical Instruments Industry	# 18
Healthcare Sector	# 800
Overall Market	# 3172

Quick Ratio Statistics
High	Average	Low
3.15	0.69	0.08
(Dec 31 2010)		(Dec 31 2024)

Financial Statements
Harvard Bioscience Inc 's Current Liabilities	$ 25 Millions	Visit HBIO's Balance sheet
Harvard Bioscience Inc 's Cash & cash equivalent	$ 7 Millions	Visit HBIO's Balance sheet
Source of HBIO's Sales		Visit HBIO's Sales by Geography

Cumulative Harvard Bioscience Inc 's Quick Ratio

HBIO's Quick Ratio for the trailling 12 Months

HBIO Quick Ratio	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months	(Jun 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	-34.07 %	0.91 %	52.19 %	130.17 %	83.56 %
Y / Y Cash & cash equivalent TTM Growth	34 %	64.04 %	67.37 %	39.39 %	20.86 %
Quick Ratio TTM	0.25	0.21	0.16	0.12	0.12
Total Ranking TTM	# 4089	# 2930	# 2527	# 3306	# 3105
Seq. Current Liabilities TTM Growth	-19.16 %	-18.35 %	-15.77 %	18.6 %	23.72 %
Seq. Cash & cash equivalent TTM Growth	-3.13 %	5.46 %	18.84 %	10.38 %	18.58 %

Quick ratio ranking by company, industry and sector >> Back to HBIO Financial Strength Comparisons >> Go to Compare HBIO Quick Ratio to its Competitors

On the trailing twelve months basis Current Liabilities decreased faster than Harvard Bioscience Inc 's average Cash & cash equivalent, this led to increase in in Harvard Bioscience Inc 's Quick Ratio to 0.25, Quick Ratio remained below HBIO average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Laboratory Analytical Instruments industry 22 other companies have achieved higher Quick Ratio than Harvard Bioscience Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 2930 to 4089.

Explain Quick Ratio?
How much Cash & cash equivalents HBIO�s has?
What are HBIO�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Laboratory Analytical Instruments Industry	# 23
Healthcare Sector	# 908
Within the Market	# 4089

trailing twelve months Quick Ratio Statistics
High	Average	Low
2.18	0.59	0.11
(Sep 30 2013)		(Sep 30 2025)

Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Laboratory Analytical Instruments Industry	Quick Ratio	Jun 30 2026 MRQ Cash & cash equivalent	Jun 30 2026 MRQ Current Liabilities
Revvity Inc	0.67	$ 1,022.943 Millions	$ 1,516.157 Millions
Harvard Bioscience Inc	0.26	$ 6.503 Millions	$ 24.793 Millions
Waters Corporation	0.22	$ 539.000 Millions	$ 2,399.000 Millions
Kewaunee Scientific Corporation	0.22	$ 10.261 Millions	$ 47.235 Millions
Bruker Corporation	0.18	$ 217.200 Millions	$ 1,204.700 Millions
Illumina Inc	0.07	$ 128.000 Millions	$ 1,717.000 Millions

Date modified: 2026-09-08T18:02:22+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.